MYBPC3 Gene Cardiomyopathy familial hypertrophic type 4 Genetic Test sale cost 4400 AED
EYA4 Gene Cardiomyopathy dilated type 1J Genetic Test sale cost 4400 AED EYA4 Gene Cardiomyopathy dilated type 1J Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
DSP Gene Dilated cardiomyopathy with woolly hair keratoderma and tooth agenesis Genetic Test sale cost 4400 AED DSP Gene Dilated cardiomyopathy with woolly hair keratoderma and tooth agenesis Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

MYBPC3 Gene Cardiomyopathy familial hypertrophic type 4 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MYBPC3 gene plays a critical role in the structure and function of the heart muscle. Mutations in this gene are a common cause of familial hypertrophic cardiomyopathy (HCM), a condition characterized by thickening of the heart muscle, which can lead to heart failure and sudden cardiac death. Familial hypertrophic cardiomyopathy type 4 specifically refers to the subtype linked to mutations in the MYBPC3 gene.

The genetic test for MYBPC3-associated familial hypertrophic cardiomyopathy type 4 is a vital diagnostic tool. It involves analyzing the patient’s DNA to identify mutations in the MYBPC3 gene that are known to cause the condition. This test is crucial not only for diagnosing affected individuals but also for identifying at-risk family members who may benefit from regular cardiac monitoring or preventive treatments.

DNA Labs UAE offers this specialized genetic test, providing a reliable means of diagnosing MYBPC3 gene cardiomyopathy. The test is priced at 4400 AED and is conducted in their state-of-the-art facilities, ensuring accuracy and confidentiality. By opting for this test, individuals and families can gain essential insights into their genetic health, paving the way for informed medical and lifestyle decisions to manage or mitigate the risks associated with familial hypertrophic cardiomyopathy type 4.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MYBPC3 Gene Cardiomyopathy familial hypertrophic type 4 Genetic Test

Components:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Cardiovascular Pneumology Disorders
  • Doctor: Cardiologist
  • Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for MYBPC3 Gene Cardiomyopathy, familial hypertrophic type 4 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MYBPC3 Gene Cardiomyopathy, familial hypertrophic type 4 NGS Genetic DNA Test gene MYBPC3.

Test Details:

MYBPC3 gene cardiomyopathy, familial hypertrophic type 4 is a type of genetic disorder that affects the heart muscle. It is caused by mutations in the MYBPC3 gene, which provides instructions for making a protein called cardiac myosin-binding protein C. This protein is involved in regulating the contraction of heart muscle cells.

Familial hypertrophic cardiomyopathy (FHC) is a condition characterized by abnormal thickening (hypertrophy) of the heart muscle, particularly the left ventricle. This can lead to symptoms such as shortness of breath, chest pain, fatigue, and an increased risk of heart failure and sudden cardiac death.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously. In the context of MYBPC3 gene cardiomyopathy, NGS genetic testing can identify mutations or variations in the MYBPC3 gene that may be responsible for the development of familial hypertrophic cardiomyopathy.

By detecting these genetic changes, NGS genetic testing can help diagnose individuals with familial hypertrophic cardiomyopathy, identify individuals at risk of developing the condition, and inform appropriate management and treatment strategies. It can also provide information for family members who may be at risk of inheriting the condition.

It is important to note that genetic testing should be performed and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors, who can provide appropriate counseling and guidance based on the test results.

Test Name MYBPC3 Gene Cardiomyopathy familial hypertrophic type 4 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MYBPC3 Gene Cardiomyopathy, familial hypertrophic type 4 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MYBPC3 Gene Cardiomyopathy, familial hypertrophic type 4 NGS Genetic DNA Test gene MYBPC3
Test Details

MYBPC3 gene cardiomyopathy, familial hypertrophic type 4 is a type of genetic disorder that affects the heart muscle. It is caused by mutations in the MYBPC3 gene, which provides instructions for making a protein called cardiac myosin-binding protein C. This protein is involved in regulating the contraction of heart muscle cells.

Familial hypertrophic cardiomyopathy (FHC) is a condition characterized by abnormal thickening (hypertrophy) of the heart muscle, particularly the left ventricle. This can lead to symptoms such as shortness of breath, chest pain, fatigue, and an increased risk of heart failure and sudden cardiac death.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously. In the context of MYBPC3 gene cardiomyopathy, NGS genetic testing can identify mutations or variations in the MYBPC3 gene that may be responsible for the development of familial hypertrophic cardiomyopathy.

By detecting these genetic changes, NGS genetic testing can help diagnose individuals with familial hypertrophic cardiomyopathy, identify individuals at risk of developing the condition, and inform appropriate management and treatment strategies. It can also provide information for family members who may be at risk of inheriting the condition.

It is important to note that genetic testing should be performed and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors, who can provide appropriate counseling and guidance based on the test results.

SKU: TEST-3404 Category:

Related products